NumerixS Investment Technologies’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-9,086
Closed -$628K 288
2020
Q2
$628K Buy
9,086
+2,057
+29% +$146K 0.18% 124
2020
Q1
$442K Sell
7,029
-1,071
-13% -$77.2K 0.23% 95
2019
Q4
$630K Buy
+8,100
New +$632K 0.12% 187
2019
Q3
Sell
-4,500
Closed -$277K 1077
2019
Q2
$277K Buy
+4,500
New +$272K 0.08% 309
2018
Q1
Sell
-17,100
Closed -$642K 1108
2017
Q4
$642K Buy
17,100
+3,600
+27% +$132K 0.15% 167
2017
Q3
$492K Sell
13,500
-15,900
-54% -$606K 0.11% 229
2017
Q2
$1.16M Sell
29,400
-43,551
-60% -$1.59M 0.17% 144
2017
Q1
$2.29M Buy
+72,951
New +$2.28M 0.26% 82
2016
Q4
Sell
-14,400
Closed -$579K 1180
2016
Q3
$579K Sell
14,400
-4,800
-25% -$181K 0.07% 333
2016
Q2
$638K Buy
+19,200
New +$657K 0.09% 324
2015
Q3
Sell
-36,600
Closed -$869K 687
2015
Q2
$869K Sell
36,600
-51,216
-58% -$1.16M 0.12% 229
2015
Q1
$2.08M Buy
+87,816
New +$1.97M 0.38% 59

Other funds holding EW

NumerixS Investment Technologies's EW Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Edwards Lifesciences (EW) in Q3 2020, closing a stake of 9,086 shares — an estimated $628K sold.

NumerixS Investment Technologies first reported a position in EW in Q1 2015 and held it in 12 quarters. The position peaked at $2.29M in Q1 2017. 1,083 funds tracked by Wall St. Rank hold EW as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Edwards Lifesciences position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 9,086 Edwards Lifesciences shares in Q3 2020, an estimated $628K.
  • NumerixS Investment Technologies first reported a position in Edwards Lifesciences in Q1 2015 and held it in 12 quarters.
  • NumerixS Investment Technologies's Edwards Lifesciences position peaked at $2.29M in Q1 2017.
  • 1,083 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.